TrialBeacon
EUClinicalTrials.govClinical trialRecruiting

SpaceOAR Post-Market Registry Study

Official record

Identifier
NCT07300631
Recruiting locations

countries

FranceUnited Kingdom
Interventions studied
SpaceOAR / SpaceOAR Vue hydrogel system
Lead sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Target enrolment
320 participants
Study type
OBSERVATIONAL
Phase
Not provided in the official record
Status
Recruiting
First posted
Dec 24, 2025
Last updated on the registry
Jul 30, 2026
Age
18 Years
Sex
MALE
Study contact
No public contact is listed on the official record.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* All patients with a clinical diagnosis of prostate cancer planned to undergo treatment with curative intent at selected sites in the UK \& France subject to a SpaceOAR being used as usual care.
* Aged 18 years old or above.
* Patients who agrees to participate and has been deemed by their medical team to have capacity to provide;

  * verbal, informed consent over telephone as documented on the study informed consent form by the Researchers (UK only)
  * written, informed consent by signature of the study informed consent form (France only)
* Patient covered by social security scheme (France only)

Exclusion Criteria:

\- Patients lacking the capacity to provide;

* informed consent as documented on the study informed consent form by the - Researchers (UK only)
* written, informed consent by signature of the study informed consent form (France only)
Indexed under
Prostate Cancer

This site does not provide medical advice

TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.